Medrol: Potent Glucocorticoid for Effective Inflammation Control
| Product dosage: 16mg | |||
|---|---|---|---|
| Package (num) | Per pill | Price | Buy |
| 30 | $3.94 | $118.14 (0%) | 🛒 Add to cart |
| 60 | $2.75 | $236.29 $165.20 (30%) | 🛒 Add to cart |
| 90 | $2.37 | $354.43 $213.26 (40%) | 🛒 Add to cart |
| 120 | $2.17 | $472.58 $260.32 (45%) | 🛒 Add to cart |
| 180 | $1.97 | $708.86 $354.43 (50%) | 🛒 Add to cart |
| 270 | $1.84
Best per pill | $1063.30 $497.61 (53%) | 🛒 Add to cart |
| Product dosage: 4mg | |||
|---|---|---|---|
| Package (num) | Per pill | Price | Buy |
| 60 | $0.90 | $54.07 (0%) | 🛒 Add to cart |
| 90 | $0.81 | $81.10 $73.09 (10%) | 🛒 Add to cart |
| 120 | $0.78 | $108.13 $93.11 (14%) | 🛒 Add to cart |
| 180 | $0.72 | $162.20 $130.16 (20%) | 🛒 Add to cart |
| 270 | $0.70 | $243.30 $190.23 (22%) | 🛒 Add to cart |
| 360 | $0.68
Best per pill | $324.40 $246.30 (24%) | 🛒 Add to cart |
Synonyms | |||
Medrol (methylprednisolone) is a synthetic glucocorticoid corticosteroid medication designed to manage a wide spectrum of inflammatory and autoimmune conditions. It functions by modulating the body’s immune response, effectively reducing inflammation and suppressing inappropriate immune activity. This makes it a cornerstone therapy in numerous clinical scenarios, from acute allergic reactions to chronic rheumatic diseases. Its predictable pharmacokinetic profile and established efficacy have solidified its position as a trusted agent in both hospital and outpatient settings.
Features
- Active ingredient: Methylprednisolone
- Drug class: Synthetic glucocorticoid corticosteroid
- Available formulations: Oral tablets (2 mg, 4 mg, 8 mg, 16 mg, 32 mg), injectable solutions
- Rapid onset of anti-inflammatory and immunosuppressive action
- Multiple dosage strengths allow for precise titration
Benefits
- Provides rapid and potent suppression of inflammatory processes, alleviating pain, swelling, and redness.
- Effectively modulates the immune system to control hyperactive immune responses seen in autoimmune disorders.
- Can be used in a wide range of conditions, offering a versatile therapeutic option for clinicians.
- The availability of a dose pack facilitates a structured tapering regimen, helping to mitigate adrenal suppression upon discontinuation.
- Offers predictable pharmacokinetics, allowing for reliable dosing schedules and outcome expectations.
Common use
Medrol is indicated for a broad array of conditions where anti-inflammatory or immunosuppressive effects are desired. Its common uses include, but are not limited to: endocrine disorders such as congenital adrenal hyperplasia; rheumatic disorders like rheumatoid arthritis, psoriatic arthritis, and acute gouty arthritis; collagen diseases including systemic lupus erythematosus and acute rheumatic carditis; dermatologic conditions such as severe psoriasis and exfoliative dermatitis; allergic states that are refractory to conventional treatment; ophthalmic diseases involving the eye and its adnexa; respiratory diseases like symptomatic sarcoidosis and aspiration pneumonitis; hematologic disorders including acquired hemolytic anemia; neoplastic diseases for palliative management; edematous states; gastrointestinal diseases such as ulcerative colitis; and nervous system conditions like acute exacerbations of multiple sclerosis. It is also used for the suppression of allograft rejection in organ transplantation.
Dosage and direction
Dosage of Medrol must be individualized based on the severity of the condition and the patient’s response. The initial dosage may vary from 4 mg to 48 mg of methylprednisolone per day, administered as a single daily dose or in divided doses. Conditions that are less severe usually require lower doses, while severe conditions may necessitate higher initial doses. The dosage should be decreased gradually, in small increments, until the lowest dose that maintains an adequate clinical response is reached. If after a reasonable period there is a lack of satisfactory clinical response, discontinue Medrol and transfer the patient to other therapy. Abrupt discontinuation of therapy after prolonged treatment is hazardous and can precipitate adrenal insufficiency. Therapy must always be tapered. The Medrol Dose Pack provides a convenient 21-tablet regimen that guides a 6-day tapering schedule, starting at 24 mg on day one. Administration with food is recommended to minimize potential gastrointestinal upset.
Precautions
Generalized precautions are paramount when administering corticosteroid therapy. Patients should be closely monitored for alterations in cardiovascular, renal, gastrointestinal, neurological, and endocrine function. Use caution in patients with hypothyroidism, cirrhosis, ocular herpes simplex, emotional instability, or psychotic tendencies. Corticosteroids can mask signs of infection and new infections may appear during their use. Prolonged use may produce posterior subcapsular cataracts, glaucoma with possible damage to the optic nerves, and secondary ocular infections due to fungi or viruses. Average and large doses of hydrocortisone or cortisone can cause elevation of blood pressure, salt and water retention, and increased excretion of potassium. All corticosteroids increase calcium excretion. Vaccination administration during corticosteroid therapy may pose a risk of neurological complications and lack of antibody response. Use with extreme caution in patients with known or suspected Strongyloides (threadworm) infestation.
Contraindications
Medrol is contraindicated in patients with known hypersensitivity to methylprednisolone or any component of the formulation. Systemic fungal infections are an absolute contraindication. Live or live-attenuated vaccines should not be administered to individuals who are immunosuppressed, including those on immunosuppressive doses of corticosteroids. Its use is also contraindicated for intrathecal administration due to the risk of severe adverse events.
Possible side effect
Side effects are generally dose- and duration-dependent. Possible effects include:
- Endocrine: Cushing’s syndrome, menstrual irregularities, development of cushingoid state, suppression of growth in children, secondary adrenocortical and pituitary unresponsiveness.
- Fluid and electrolyte disturbances: Sodium retention, fluid retention, congestive heart failure in susceptible patients, potassium loss, hypokalemic alkalosis, hypertension.
- Musculoskeletal: Muscle weakness, steroid myopathy, loss of muscle mass, osteoporosis, vertebral compression fractures, aseptic necrosis of femoral and humeral heads, pathologic fracture of long bones.
- Gastrointestinal: Peptic ulcer with possible perforation and hemorrhage, pancreatitis, abdominal distention, ulcerative esophagitis.
- Dermatologic: Impaired wound healing, thin fragile skin, petechiae and ecchymoses, facial erythema.
- Neurological: Convulsions, increased intracranial pressure with papilledema (pseudotumor cerebri), vertigo, headache.
- Ophthalmic: Posterior subcapsular cataracts, increased intraocular pressure, glaucoma, exophthalmos.
- Metabolic: Negative nitrogen balance due to protein catabolism.
- Psychiatric: Euphoria, insomnia, mood swings, personality changes, severe depression, frank psychotic manifestations.
Drug interaction
Methylprednisolone can interact with numerous medications, necessitating careful review of a patient’s complete drug regimen.
- Anticoagulants: Corticosteroids may alter the response to anticoagulants, necessitating frequent monitoring of coagulation indices.
- Antidiabetic agents: Corticosteroids may increase blood glucose concentrations, requiring dosage adjustments of insulin or oral hypoglycemic agents.
- Cyclosporine: Increased plasma concentrations of both drugs may occur; convulsions have been reported with this combination.
- Enzyme Inducers: Drugs such as phenobarbital, phenytoin, and rifampin may increase the clearance of methylprednisolone, requiring dosage adjustments.
- Enzyme Inhibitors: Drugs like ketoconazole and macrolide antibiotics (e.g., erythromycin) may inhibit the metabolism of corticosteroids.
- NSAIDs: Concomitant use of aspirin (or other NSAIDs) and corticosteroids increases the risk of gastrointestinal ulceration.
- Diuretics: Enhances potassium excretion; patients on diuretics which also cause potassium loss are at increased risk of hypokalemia.
- Live Vaccines: Do not administer live or live-attenuated vaccines to patients on immunosuppressive corticosteroid doses.
Missed dose
If a dose is missed, it should be taken as soon as it is remembered. However, if it is almost time for the next scheduled dose, the missed dose should be skipped and the regular dosing schedule resumed. Do not double the dose to make up for a missed one. Maintaining the prescribed tapering schedule is critical; a missed dose during a taper should be discussed with the prescribing physician for guidance.
Overdose
Acute overdosage with methylprednisolone is not expected to produce acute, life-threatening symptoms. The potential for toxicity is primarily associated with chronic overdose, manifesting as signs and symptoms of hypercorticism (Cushing’s syndrome). There is no specific antidote. Treatment of acute ingestion consists of supportive and symptomatic therapy. In the case of chronic overdose, the corticosteroid dosage should be reduced gradually.
Storage
Store Medrol tablets at controlled room temperature, 20°C to 25°C (68°F to 77°F), with excursions permitted between 15°C and 30°C (59°F and 86°F). Protect from light and moisture. Keep all medications out of the reach of children and pets. Do not flush medications down the toilet or pour them into a drain unless instructed to do so. Properly discard this product when it is expired or no longer needed.
Disclaimer
This information is for educational and informational purposes only and does not constitute medical advice. It is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition or medication. Never disregard professional medical advice or delay in seeking it because of something you have read here. The content has been compiled from various sources believed to be accurate and reliable, however, no guarantee is made to that effect. The drug information contained herein is subject to change and is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects.
Reviews
- “As a rheumatologist, Medrol is an indispensable tool for managing acute flares in my autoimmune patients. The dose pack provides a structured, easy-to-follow taper that improves patient compliance.” – Dr. A. Sharma, MD
- “Prescribed for a severe allergic contact dermatitis. The inflammation and itching subsided significantly within 48 hours. The taper was straightforward with the provided pack.” – Patient M.T.
- “Used in a hospital setting for managing acute exacerbation of COPD. The anti-inflammatory effect on the airways is rapid and highly effective, often preventing the need for intubation.” – Critical Care RN, J. Corbin
- “Effective for controlling my polymyalgia rheumatica symptoms, allowing for return to normal function. Requires careful monitoring by my doctor for any side effects with long-term use.” – Patient R.L.